ArticleJournal of pharmacy & bioallied sciences2025
Clinicopathological and Radiological Correlation in Osteosarcoma: A Prospective Study of 91 Cases.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteosarcoma is the most common primary malignant bone tumor, primarily affecting adolescents during rapid bone growth. Materials and Methods: A prospective study of 91 cases of osteosarcoma diagnosed at Gujarat Cancer and Research Institute, Ahmedabad (2014-2016). Clinical history, radiological imaging (X-ray, CT, MRI), and histopathological findings (H&E staining) were analyzed. Correlation with radiological features such as cortical breach, periosteal reaction, and soft tissue extension was evaluated. Results: Peak incidence: Second decade (60.4%), with a male-to-female ratio of 1.6:1. Common sites: Distal femur (39.6%), proximal tibia (30.7%), and proximal humerus (9.9%). Histopathological subtypes: Osteoblastic (44%), chondroblastic (22%), fibroblastic (11%), MFH-type (8.8%), giant cell-rich (4.4%), telangiectatic (4.4%), parosteal (3.3%), and small cell (2.1%). Radiological accuracy: Parosteal (100%) and small cell (100%) had the highest radiological correlation, while giant cell-rich osteosarcoma (25%) was frequently misdiagnosed. Cortical breach and periosteal reaction were observed in 92.6% of cases. Conclusion: Osteosarcoma predominantly affects adolescents, with metaphyseal long bone involvement. Radiology aids in primary diagnosis but lacks subtype specificity. Histopathology remains the gold standard, necessitating a multidisciplinary approach for precise diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.